Breaking News
Investing Pro 0
💎 Reveal Undervalued Stocks Hiding in Any Market Get Started

Stocks - Dow Gets Hit Late as Vaccine Optimism Cools

Stock Markets May 19, 2020 04:15PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.
 
US500
+0.56%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
DJI
+0.41%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
C
-0.78%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GS
-0.72%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
JPM
-1.52%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
WMT
+0.82%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Yasin Ebrahim

Investing.com – Late-selling hit the Dow on Tuesday, as investor sentiment was soured by a report suggesting that Moderna 's potential Covid-19 vaccine may not be as effective as many believe.

The Dow Jones Industrial Average fell 1.59%, or 390 points, the S&P 500 fell 1.07%, while the Nasdaq Composite slipped 0.54%.

Moderna (NASDAQ:MRNA) came under pressure after a STAT News report cooled some of the optimism surrounding the company's potential Covid-19 vaccine. The company also announced a secondary stock offering that would raise more than $1 billion. 

"Several vaccine experts asked by STAT concluded that, based on the information made available by the Cambridge, Mass.-based company, there’s really no way to know how impressive — or not — the (Moderna) vaccine may be,"  STAT News reported.

Moderna had rallied about 20% a day earlier, after announcing positive early-stage clinical results for its potential Covid-19 vaccine.

The downbeat news offset supportive remarks from Federal Reserve Chairman Jay Powell and U.S. Treasury Secretary Steven Mnuchin.

Just days after suggesting the Fed had plenty of ammunition left to support the economy through the pandemic, Federal Reserve Chairman Powell reiterated the central bank's supportive stance on monetary policy.

"We are committed to using our full range of tools to support the economy in this challenging time even as we recognize that these actions are only a part of a broader public-sector response,” Powell said Tuesday in remarks to the Senate Banking Committee.

Powell also said he expected the Fed would roll out its Main Street lending and other programs by the end of the month.

Mnuchin, meanwhile, said he expected the economy to recover in the third or fourth quarter and floated the idea of middle-class tax cuts.

Financials fell as investors continue to shun bank stocks on expectations a lower-for-longer interest-rate environment will hurt net interest income.

JPMorgan Chase (NYSE:JPM) fell 1.8%, Goldman Sachs (NYSE:GS) slipped 2.14% and Citigroup (NYSE:C) fell 2.7%.

Investors also had to contend with a turn lower in retail stocks following mixed quarterly results from corporates.

Walmart (NYSE:WMT) gave up gains to close 2.19% lower despite posting quarterly results that topped analysts;' estimates. The beat was driven a 74% surge in U.S. e-commerce sales in the first quarter, as coronavirus-led stockpiling of groceries and household goods bolstered growth.

Home Depot (NYSE:HD) fell 2.6% after the home-improvement retailer reported profits that missed analysts' forecasts.

Department store chain Kohls (NYSE:KSS) fell 7.68% after reporting a wider-than-expected loss and revenue that fell short of expectations in the first quarter.

In tech, Facebook (NASDAQ:FB) climbed 1.76% as it launched a new shopping feature to make easier for companies to sell products on Facebook and Instagram.

Spotify (NYSE:SPOT) jumped 8.41% after inking a multi-year deal to acquire the exclusive rights to world-famous podcast 'The Joe Rogan Experience,' which reportedly racked in about 190 million downloads per month last year.

Energy stocks also contributed to selloff despite oil prices settling higher on growing optimism for a recovery in crude demand.

On the economic front, U.S. housing starts plunged to a record 30.2% in April, pressuring the annual pace down from 1.276 million, revised higher from 1.216 million, to 891 million, the weakest pace since Feb. 2015, according to Jefferies (NYSE:JEF).

Stocks - Dow Gets Hit Late as Vaccine Optimism Cools
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (20)
John Eads
John Eads May 20, 2020 7:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bynb is the best stock on the market!
Eda Mucha
Eda Mucha May 20, 2020 7:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bnb your *****et
Sam Crowther
Sam Crowther May 20, 2020 12:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Has anyone ever stopped to think that in 150 years of market data we are still in an upward positive trend...never the less to mention that our technological and scientific advancement is extraordinarily perpetual...everything is so cyclical but yet shorts and bearish mentality cant unhinge themselves from their dramatized life style
Frank Cortinas IV
Frank Cortinas IV May 19, 2020 10:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MRNA overvalued. Changing my mind.
Bulls MakeMore
Bulls MakeMore May 19, 2020 9:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This market is driven mostly by vaccine and reopening news, secondarily by the Fed.
maro turk
maro turk May 19, 2020 9:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ok yesterday market up dollar down. Today market down, dollar down, gold up. Let's go for it gold bugs. That is only that makes sense.BUY GOLD!
Randall Wagner
Randall Wagner May 19, 2020 8:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
In the long run it is long.
El Nino
El Nino May 19, 2020 7:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why is it whenever they show floor traders, they only show the ones that went long?
Tricky Dick
TrickyDick May 19, 2020 7:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why is it when they show floor traders they only use pictures from 1989?
Robert DZ the patterns
Robert DZ the patterns May 19, 2020 7:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I need 12% correction.
BJ Chandler
BJ Chandler May 19, 2020 6:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Before interpreting news, why not start with the article from STAT that kicked off the market slide today?  https://www.statnews.com/2020/05/19/vaccine-experts-say-moderna-didnt-produce-data-critical-to-assessing-covid-19-vaccine/. The author buried three important facts down in the article.  1) The test was conducted by the NIH in conjunction with Moderna, Inc.  2) An NIH expert stated the response was promising.  3) A full report will be published by NIH/Moderna shortly. The author's article headline seems fabricated to seed doubt.  Looks like something competitors would write.
Muhamed Jaffir
Muhamed Jaffir May 19, 2020 6:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I don't need a STAT article to tell me that 8 out of 45 in a small test is not good. The only real positive is that none of them seemed to suffer adverse effects. This rush to believe in a hyped up vaccine is hope ignoring science. talk to me in a year and a real trial and I might get excited. At best they are on the right track for something long into the future.
BJ Chandler
BJ Chandler May 19, 2020 6:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Located at the bottom of the STAT article was a quote from Anna Durbin, a vaccine researcher at Johns Hopkins University: “I would like to see the data to make my own interpretation of the data. But I think it is at least encouraging that we’ve seen immune responses with this RNA vaccine that we haven’t seen with previous RNA vaccines for other pathogens. Whether it’s going to be enough, we don’t know." If 8 was enough for her to be encouraged its enough for me.  This is only Phase 1.  Nobody pretended they solved it all.
Matthew Mover
Matthew Mover May 19, 2020 6:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Muhamed Jaffir  Muhamed Jaffir New vac/medications have to be dosed correctly to prevent you from being outside of the therapeutic window which could lead to toxicity, or no therapeutic effect. (1) The participants were given low doses of the vac/medication to determine the trough levels. (2) After the trough they work on the peak levels (3) 8 out of 45 were successful on a low dose. That is EXTREMLY PROMISING.
Dietmar Stahl
Dietmar Stahl May 19, 2020 6:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Moderna has the best bet to get to a vaccine. If it creates anti bodies that's all you need. What you not need is a Stat report.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email